Cell cycle protein profile of the hepatic stellate cells (HSCs) in dimethylnitrosamine-induced rat hepatic fibrosis

被引:13
|
作者
Kim, MR
Kim, HS
Lee, MS
Lee, MJ
Jang, JJ
机构
[1] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea
[2] Inje Univ, Ilsan Paik Hosp, Dept Pathol, Koyang 411706, Gyeonggi, South Korea
[3] Kangwon Natl Univ, Dept Vet, Lab Anim Med & Sci, Chunchon 200701, Kangwon, South Korea
来源
EXPERIMENTAL AND MOLECULAR MEDICINE | 2005年 / 37卷 / 04期
关键词
cell cycle; cell cycle proteins; dimethylnitrosamine; hepatic fibrosis; liver regeneration; rat;
D O I
10.1038/emm.2005.43
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell cycle regulating proteins are known to have close relation with the proliferation of the mammalian cells. In injured liver, the number of HSCs is increased from proliferation. However, the expression of cell cycle proteins of HSCs during proliferation remains unevaluated. Therefore, cell cycle protein profiles of HSCs were studied in dimethyl-nitrosamine (DMN)-induced rat liver fibrosis model. Sprague-Dawley rats were intraperitoneally injected of DMN and the animals were sacrificed every week up to 4 weeks. HSCs were separated and the number of the cells in S phase was counted to evaluate the cell proliferation by flow cytometry. The expression of cyclin A, cyclin B, cyclin D1, cdk2, cdk4, cdc2, proliferating cell nuclear antigen (PCNA), p21(Cip.WAF1), and p27 was examined with immunoblotting analysis. Portion of S-phase cells peaked 7 days after DMN injection. At that time, cyclin A, and PCNA showed significant increase in HSCs compared to untreated HSCs 114% and 116%, respectively, P < 0.001). p21 (Cip/WAF1) was decreased significantly in DMN-treated HSCs compared to control cells (88%, P < 0.001). The increase of cyclin A, and PCNA and the decrease of p21(Cip/WAF1) seem to play important roles in the proliferation of HSCs during the early period of DMN treatment.
引用
收藏
页码:335 / 342
页数:8
相关论文
共 50 条
  • [21] ROLE OF HEPATIC STELLATE CELLS (HSCs) IN THE DEVELOPMENT OF HEPATIC FIBROSIS IN CATS WITH POLYCYSTIC KIDNEY DISEASE (PKD)
    Sanja, Aleksic-Kovacevic
    Kukolj, V
    Kureljusic, B.
    Marinkovic, D.
    Knezevic, D.
    Ignjatovic, I.
    Jovanovic, M.
    Milijana, Knezevic
    Gledic, D.
    ACTA VETERINARIA-BEOGRAD, 2010, 60 (04): : 391 - 400
  • [22] Activity change of sphingomyelin catabolic enzymes during dimethylnitrosamine-induced hepatic fibrosis in rats
    Sacket, Santosh J.
    Im, Dong-Soon
    BIOMOLECULES & THERAPEUTICS, 2008, 16 (01) : 34 - 39
  • [23] Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis
    Peschl, Vanessa
    Seitz, Tatjana
    Sommer, Judith
    Thasler, Wolfgang
    Bosserhoff, Anja
    Hellerbrand, Claus
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (10) : 1544 - 1552
  • [24] A Chinese herbal medicine, Gexia-Zhuyu Tang (GZT), prevents dimethylnitrosamine-induced liver fibrosis through inhibition of hepatic stellate cells proliferation
    Chen, Jiun-Yu
    Chen, Hsiao-Ling
    Cheng, Ju-Chien
    Lin, Hung-Jen
    Tung, Yu-Tang
    Lin, Chia-Fan
    Chen, Chuan-Mu
    JOURNAL OF ETHNOPHARMACOLOGY, 2012, 142 (03) : 811 - 818
  • [25] Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis
    Sferra, Roberta
    Vetuschi, Antonella
    Pompili, Simona
    Gaudio, Eugenio
    Speca, Silvia
    Latella, Giovanni
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (01) : 58 - 65
  • [26] Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats
    Yang, Tao
    Zheng, Tian-Hui
    Zhao, Qiang
    Liu, Wei
    Li, Shu-Ping
    Tao, Yan-Yan
    Wang, Chang-Hong
    Liu, Cheng-Hai
    PHARMACEUTICAL BIOLOGY, 2020, 58 (01) : 1 - 7
  • [27] Protective effect of cultured bear bile powder against dimethylnitrosamine-induced hepatic fibrosis in rats
    Zheng, Min
    Li, Yuan-Yuan
    Wang, Guo-Feng
    Jin, Jing-Yi
    Wang, Ya-Hang
    Wang, Tian-Ming
    Yang, Li
    Liu, Shao-Yong
    Wu, Jia-Sheng
    Wang, Zheng-Tao
    Ma, Yue-Ming
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 112
  • [28] Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats
    Tsuruta, S
    Nakamuta, M
    Enjoji, M
    Kotoh, K
    Hiasa, K
    Egashira, K
    Nawata, H
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2004, 14 (05) : 837 - 842
  • [29] A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats
    Tada, S
    Iwamoto, H
    Nakamuta, M
    Sugimoto, R
    Enjoji, M
    Nakashima, Y
    Nawata, H
    JOURNAL OF HEPATOLOGY, 2001, 34 (04) : 529 - 536
  • [30] Gene expression profile associated with activated hepatic stellate cells: Implications for hepatic fibrosis
    Estep, JM
    O'Reilly, L
    Schlauch, K
    Grant, G
    Ong, J
    Piper, J
    Jonsson, J
    Chandhoke, V
    Smith, KM
    Younossi, ZM
    GASTROENTEROLOGY, 2004, 126 (04) : A708 - A708